US Stock · Smart-money analysis
BIIB (Biogen Inc.) is a US stock trading at $204.54, -2.10% on the day. mdvin's smart-money engine places it in the WATCHING operator phase, with a GRINDER accumulation style. Current conviction is 76/100 and the Buy Score is 70. The active signal is TREND LEADER. It has ignited 2 time(s) in the last 90 sessions, paying off 20% of the time (typical run +1.2%). Reversal/trap risk is graded LOW. On fundamentals it looks fair value (quality grade C, analyst upside +10.60%).
Snapshot updated daily; open the live deep-dive for the latest. Educational only — not investment advice.